2023年贵州省盘州市不同年龄儿童肺炎支原体肺炎临床特征分析
Clinical Characteristics Analysis of Mycoplasma Pneumoniae Pneumonia in Children of Different Ages in Panzhou City, Guizhou Province in 2023
摘要: 目的:分析不同年龄段儿童肺炎支原体肺炎的临床特征。方法:回顾性分析2023年1月至11月间盘州市第二人民医院儿科收治的86例MPP患儿的临床资料。根据年龄将患儿分为三组:<3岁,3~6岁,6岁以上,并收集其临床资料和辅助检查和治疗情况。结果:研究共纳入86名患儿,其中3岁以下20名(23.26%),3至6岁42名(48.84%),6岁以上24名(27.91%)。临床表现中,3岁以下儿童出现喘息和肺部啰音的频率最高,且肺实变在胸部影像学中的比例显著高于其他年龄组。治疗方面,3岁以下儿童组需要氧气支持的比例显著高于其他年龄组,且平均住院时间更长。结论:3岁以下儿童中肺炎支原体肺炎的临床表现更为严重,突显对3岁以下儿童进行更密切的监测和更积极的治疗策略的重要性。
Abstract: Objective: To analyze the clinical characteristics of Mycoplasma pneumoniae pneumonia (MPP) in children of different age groups. Methods: A retrospective analysis was conducted on the clinical data of 86 MPP patients admitted to the Pediatrics Department of Dianzhou Second People’s Hospital from January to November 2023. The children were divided into three age groups (<3 years, 3~6 years, and ≥6 years), and their clinical data, auxiliary examinations, and treatment details were collected. Results: A total of 86 children were enrolled, including 20 (<3 years, 23.26%), 42 (3~6 years, 48.84%), and 24 (≥6 years, 27.91%). Clinically, children under 3 years exhibited the highest frequency of wheezing and pulmonary rales, with a significantly higher proportion of pulmonary consolidation on chest imaging compared to other age groups. In terms of treatment, the proportion requiring oxygen support was significantly higher in the <3-year-old group, and their average hospital stay was longer. Conclusion: MPP in children under 3 years presents more severe clinical manifestations, underscoring the importance of closer monitoring and more aggressive treatment strategies for this age group.
文章引用:任贞舟, 王权. 2023年贵州省盘州市不同年龄儿童肺炎支原体肺炎临床特征分析[J]. 临床医学进展, 2026, 16(7): 1780-1784. https://doi.org/10.12677/acm.2026.1672701

参考文献

[1] 吴立强. 不同年龄阶段肺炎支原体肺炎合并细菌感染患儿维生素A水平差异及对预后的预测[J]. 中国免疫学杂志, 2026, 42(7): 1708-1714.
[2] 高振鹏, 叶莹莹, 张永平, 等. 重症肺炎支原体肺炎患儿发生塑形性支气管炎相关因素及Nomogram模型构建[J]. 公共卫生与预防医学, 2026, 37(4): 123-128.
[3] 王亚翠, 吴喜蓉, 刘芳, 等. 2016年至2019年北京住院儿童肺炎支原体感染流行病学特征和耐药性[J]. 中华实用儿科临床杂志, 2022, 37(14): 1082-1085.
[4] 中华人民共和国国家卫生健康委员会. 儿童肺炎支原体肺炎诊疗指南(2023年版) [J]. 中国合理用药探索, 2023, 20(3): 16-24.
[5] 王美祎, 翟志娜, 步晓濛, 等. 血清Notch1、PKM2水平与重症肺炎支原体肺炎患儿炎症反应及预后转归的关系[J]. 检验医学与临床, 2026, 23(13): 1795-1801+1807.
[6] 孟宝宝, 戚琼. 难治性支原体肺炎患儿血清CHI3L1、ET-1、D-D水平与气道反应性的关系及诊断价值分析[J]. 贵州医药, 2026, 50(7): 1082-1085.
[7] 李夏, 王静. 延续性护理联合健康宣教在肺炎支原体肺炎患儿护理中的应用价值[J]. 延边大学医学学报, 2026, 49(6): 137-139.
[8] 李倩龙, 周碧, 杨林风. 基于IKAP理论的护理干预在雾化吸入仪治疗支原体肺炎患儿中的应用价值[J]. 生命科学仪器, 2026, 24(3): 260-262.
[9] 麻文广, 何文红, 赵迁, 等. 双歧杆菌乳杆菌三联活菌联合阿奇霉素在肺炎支原体肺炎伴腹泻患儿中的应用效果[J]. 临床医学研究与实践, 2026, 11(17): 90-93.
[10] 王旭, 于巍, 于晓萌, 等. 肺炎支原体肺炎合并肺栓塞患儿1例的护理体会[J]. 中国冶金工业医学杂志, 2026, 43(3): 252+259.